FDA approves first systemic treatment for alopecia areata
- Details
- Category: FDA

FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
- Details
- Category: FDA

FDA limits use of Janssen COVID-19 vaccine to certain individuals
- Details
- Category: FDA

EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
- Details
- Category: EMA

FDA approves first generic of Symbicort to treat asthma and COPD
- Details
- Category: FDA

FDA approves treatment for wider range of patients with heart failure
- Details
- Category: FDA

Jardiance was originally approved by the FDA in 2014 as a supplement to diet and exercise to improve glucose control in adults with type 2 diabetes.
EMA: Human medicines highlights of 2021
- Details
- Category: EMA

More Pharma News ...
- FDA takes key action by approving second COVID-19 vaccine
- FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults
- FDA authorizes first oral antiviral for treatment of COVID-19
- FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16- and 17-year-olds
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
- FDA takes additional actions on the use of a booster dose for COVID-19 vaccines